{"transactions":[{"id":1282090,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2025-02-05T16:24:18.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":200000,"derivative":{"exercise_price":1,"expiration_date":"2035-02-03","underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001828185-25-000010","document":"wk-form4_1738790649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000182818525000010/wk-form4_1738790649.xml","form_type":"4"}},{"id":1688142,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2024-01-04T08:55:03.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":96500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":96500,"derivative":{"exercise_price":3.7,"expiration_date":"2034-01-02","underlying":"Ordinary Shares","underlying_shares":96500},"source":{"system":"sec-edgar","filing":"0001104659-24-001166","document":"tm241766-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465924001166/tm241766-3_4seq1.xml","form_type":"4"}},{"id":1996214,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-02-23T16:56:44.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":105000,"derivative":{"exercise_price":2.4,"expiration_date":"2033-01-03","underlying":"Ordinary Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001104659-23-024805","document":"tm237643-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465923024805/tm237643-4_4seq1.xml","form_type":"4"}},{"id":2173009,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-26T16:27:10.000Z","date":"2022-08-25","kind":"sale","acquired":false,"shares":10000,"price":7.387,"value":73870.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.34 - $7.44. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":104209,"source":{"system":"sec-edgar","filing":"0001104659-22-095144","document":"tm2224672-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922095144/tm2224672-2_4seq1.xml","form_type":"4"}},{"id":2178426,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-19T16:05:31.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":500,"price":4.762,"value":2381.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":114209,"source":{"system":"sec-edgar","filing":"0001104659-22-092959","document":"tm2223471-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922092959/tm2223471-4_4seq1.xml","form_type":"4"}},{"id":2182046,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-17T16:05:17.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":1220,"price":4.8167,"value":5876.374,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":114709,"source":{"system":"sec-edgar","filing":"0001104659-22-092176","document":"tm2223471-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922092176/tm2223471-2_4seq1.xml","form_type":"4"}},{"id":2182045,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-17T16:05:17.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":2400,"price":4.753,"value":11407.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":115929,"source":{"system":"sec-edgar","filing":"0001104659-22-092176","document":"tm2223471-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922092176/tm2223471-2_4seq1.xml","form_type":"4"}},{"id":2185767,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-15T16:41:31.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":5000,"price":4.5,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":118329,"source":{"system":"sec-edgar","filing":"0001104659-22-091265","document":"tm2223471-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922091265/tm2223471-1_4seq1.xml","form_type":"4"}},{"id":2207119,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-23","kind":"exercise","acquired":false,"shares":3090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest and become exercisable in four equal annual installments, with the first installment vested on January 1, 2021. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6180,"derivative":{"exercise_price":0.0004,"expiration_date":"2030-01-08","underlying":"Ordinary Shares","underlying_shares":3090},"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2207118,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-23","kind":"exercise","acquired":false,"shares":2317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2020. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":2317,"derivative":{"exercise_price":0.0004,"expiration_date":"2029-08-14","underlying":"Ordinary Shares","underlying_shares":2317},"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2207117,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-23","kind":"exercise","acquired":false,"shares":1931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":0.0004,"expiration_date":"2028-02-16","underlying":"Ordinary Shares","underlying_shares":1931},"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2207116,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-24","kind":"other","acquired":true,"shares":100,"price":5.868,"value":586.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":123329,"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2207115,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-23","kind":"sale","acquired":false,"shares":8,"price":5.28,"value":42.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover the exercise price of options exercised by the Reporting Person."}],"balance_after":123229,"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2207114,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-23","kind":"exercise","acquired":true,"shares":3090,"price":0.0004,"value":1.236,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":123237,"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2207113,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-23","kind":"exercise","acquired":true,"shares":2317,"price":0.0004,"value":0.9268,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":120147,"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2207112,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-15T16:05:58.000Z","date":"2022-06-23","kind":"exercise","acquired":true,"shares":1931,"price":0.0004,"value":0.7724,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":117830,"source":{"system":"sec-edgar","filing":"0001104659-22-080206","document":"tm2221185-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922080206/tm2221185-1_4seq1.xml","form_type":"4"}},{"id":2401984,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":3090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest and become exercisable in four equal annual installments, with the first installment vested on January 1, 2021. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":9270,"derivative":{"exercise_price":0.0004,"expiration_date":"2030-01-08","underlying":"Ordinary Shares"},"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401983,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":4636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2020. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":4634,"derivative":{"exercise_price":0.0004,"expiration_date":"2029-08-14","underlying":"Ordinary Shares"},"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401982,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":5794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2019. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":1931,"derivative":{"exercise_price":0.0004,"expiration_date":"2028-02-16","underlying":"Ordinary Shares"},"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401981,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":102279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in four equal annual installments, with the first installment vested on October 16, 2018. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":0.0004,"expiration_date":"2028-02-16","underlying":"Ordinary Shares"},"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401980,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":3090,"price":0.0004,"value":1.236,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":115899,"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401979,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":4636,"price":0.0004,"value":1.8544,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":112809,"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401978,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":5794,"price":0.0004,"value":2.3176,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":108173,"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401977,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-11T19:55:56.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":102279,"price":0.0004,"value":40.9116,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":102379,"source":{"system":"sec-edgar","filing":"0001104659-22-020827","document":"tm226469-7_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020827/tm226469-7_5seq1.xml","form_type":"5"}},{"id":2401976,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-02-11T19:54:45.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":80000,"derivative":{"exercise_price":11.12,"expiration_date":"2032-01-03","underlying":"Ordinary Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-22-020825","document":"tm226469-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465922020825/tm226469-5_4seq1.xml","form_type":"4"}},{"id":2725277,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-06T16:28:50.000Z","date":"2021-05-04","kind":"purchase","acquired":true,"shares":100,"price":17,"value":1700.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001104659-21-062432","document":"tm2115262-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465921062432/tm2115262-6_4seq1.xml","form_type":"4"}},{"id":2730528,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2021-05-04T20:23:45.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":88065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on April 29, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":88065,"derivative":{"exercise_price":17,"expiration_date":"2031-04-29","underlying":"Ordinary Shares","underlying_shares":88065},"source":{"system":"sec-edgar","filing":"0001104659-21-061221","document":"tm2114558-17_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465921061221/tm2114558-17_4seq1.xml","form_type":"4"}},{"id":2730527,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83560,"kind":"person","name":"Griffiths Graham","position":1,"cik":"0001851630","reported_name":"Griffiths Graham","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2021-05-04T20:23:45.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":6054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on April 29, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6054,"derivative":{"exercise_price":17,"expiration_date":"2031-04-29","underlying":"Ordinary Shares","underlying_shares":6054},"source":{"system":"sec-edgar","filing":"0001104659-21-061221","document":"tm2114558-17_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851630/000110465921061221/tm2114558-17_4seq1.xml","form_type":"4"}}]}